Toxicological mode of action of ZnO nanoparticles: Impact on immune cells

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 184-192

  Roy, Ruchi ^a,b   Das, Mukul ^a,b   Dwivedi, Premendra D ^a,b  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

Dissolution; Inflammations; Nanoparticles; Toxicity; Zinc oxide

Indexed keywords

ZINC OXIDE NANOPARTICLE; MUTAGENIC AGENT; NANOPARTICLE; ZINC OXIDE;

ANTIGEN PRESENTING CELL; CYTOTOXICITY; DISSOLUTION; GENOTOXICITY; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INTERNALIZATION; NONHUMAN; REVIEW; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENDOCYTOSIS; LYMPHOCYTE; PARTICLE SIZE; TOXICITY;

ANIMALS; ENDOCYTOSIS; HUMANS; LYMPHOCYTES; MUTAGENS; NANOPARTICLES; PARTICLE SIZE; ZINC OXIDE;

EID: 84912021341     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.08.001     Document Type: Review

References (90)

1. Afaq F., Abidi P., Matin R., Rahman Q. Cytotoxicity, pro-oxidant effects and antioxidant depletion in rat lung alveolar macrophages exposed to ultrafine titanium dioxide. J. Appl. Toxicol. 1998, 18:307-312.
2. Akhtar M.J., Ahamed M., Kumar S., Khan M.M., Ahmad J., Alrokayan S.A. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int. J. Nanomed. 2012, 7:845-857.
3. Alarifi S., Ali D., Alkahtani S., Verma A., Ahamed M., Ahmed M., Alhadlaq H.A. Induction of oxidative stress, DNA damage, and apoptosis in a malignant human skin melanoma cell line after exposure to zinc oxide nanoparticles. Int. J. Nanomed. 2013, 8:983-993.
4. 2 and ZnO nanoparticles on human lymphocytes, dendritic cells and exosome production. Toxicol. Appl. Pharmacol. 2012, 264:94-103.
5. Arai T., Norde W. The behavior of some model proteins at solid-liquid interfaces. Sequential and competitive adsorption. Colloids Surf. 1990, 51:17-28.
6. 2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils. Toxicol. Lett. 2013, 221:57-63.
7. Baek M., Chung H.E., Yu J., Lee J.A., Kim T.H., Oh J.M., Lee W.J., Paek S.M., Lee J.K., Jeong J., Choy J.H., Choi S.J. Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int. J. Nanomed. 2012, 7:3081-3097.
8. Beckett W.S., Chalupa D.F., Pauly-Brown A., Speers D.M., Stewart J.C., Frampton M.W., Utell M.J., Huang L.S., Cox C., Zareba W., Oberdorster G. Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am. J. Respir. Crit. Care Med. 2005, 171:1129-1135.
9. Berardis B.D., Civitelli G., Condello M., Lista P., Pozzi R., Arancia G., Meschini S. Exposure to ZnO nanoparticles induces oxidative stress and cytotoxicity in human colon carcinoma cells. Toxicol. Appl. Pharmacol. 2010, 246:116-127.
10. Blanc P.D., Boushey H.A., Wong H., Wintermeyer S.F., Bernstein M.S. Cytokines in metal fume fever. Am. Rev. Respir. Dis. 1993, 147:134-138.
11. Brown S.C., Kamal M., Nasreen N., Baumuratov A., Sharma P., Antony V.B., Moudgil B.M. Influence of shape, adhesion and simulated lung mechanics on amorphous silica nanoparticles toxicity. Adv. Powder Technol. 2007, 18:69-79.
12. Brunner T.J., Wick P., Manser P., Spohn P., Grass R.N., Limbach L.K., Bruinink A., Stark W.J. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 2006, 40:4374-4381.
13. Buerki-Thurnherr T., Xiao L., Diener L., Arslan O., Hirsch C., Maeder-Althaus X., Grieder K., Wampfler B., Mathur S., Wick P., Krug H.F. In vitro mechanistic study towards a better understanding of ZnO nanoparticle toxicity. Nanotoxicology 2013, 7:402-416.
14. Chen J.K., Shih M.H., Peir J.J., Liu C.H., Chou F.I., Lai W.H., Chang L.W., Lin P., Wang M.Y., Yang M.H., Yang C.S. The use of radioactive zinc oxide nanoparticles in determination of their tissue concentrations following intravenous administration in mice. Analyst 2010, 135:1742-1746.
15. Chen W., Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J. Nanosci. Nanotechnol. 2006, 6:1159-1166.
16. 2+ dissolution inside lysosomes. Part. Fibre Toxicol. 2011, 8:27.
17. Cho W.S., Duffin R., Thielbeer F., Bradley M., Megson I.L., MacNee W., Poland C.A., Tran C.L., Donaldson K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol. Sci. 2012, 126:469-477.
18. Christman J.W., Blackwell T.S., Juurlink B.H. Redox regulation of nuclear factor kappa B: therapeutic potential for attenuating inflammatory responses. Brain Pathol. 2000, 10:153-162.
19. Cross S.E., Innes B., Roberts M.S., Tsuzuki T., Robertson T.A., McCormick P. Human skin penetration of sunscreen nanoparticles: in-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacol. Physiol. 2007, 20:148-154.
20. Deng Z.J., Mortimer G., Schiller T., Musumeci A., Martin D., Minchin R.F. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009, 20:455101.
21. Donaldson K., Stone V., Clouter A., Renwick L., MacNee W. Ultrafine particles. Occup. Environ. Med. 2001, 58:211-216.
22. Donaldson K., Stone V. Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann. Ist. Super. Sanità 2003, 39:405-410.
23. Donaldson K., Borm P.J.A., Oberdorster G., Pinkerton K.E., Stone V., Tran C.L. Concordance between in vitro and in vivo dosimetry in the proinflammatory effects of low-toxicity, low-solubility particles: the key role of the proximal alveolar region. Inhal. Toxicol. 2008, 20:53-62.
24. Dufour E.K., Kumaravel T., Nohynek G.J., Kirkland D., Toutain H. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity: genotoxic effect of zinc oxide in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mutat. Res. 2006, 607:215-224.
25. George S., Pokhrel S., Xia T., Gilbert B., Ji Z., Schowalter M., Rosenauer A., Damoiseaux R., Bradley K.A., Mädler L., Nel A.E. Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano 2010, 4:15-29.
26. Gilbert B., Fakra S.C., Xia T., Pokhrel S., Mädler L., Nel A.E. The fate of ZnO nanoparticles administered to human bronchial epithelial cells. ACS Nano 2012, 6:4921-4930.
27. Gojova A., Guo B., Kota R.S., Rutledge J.C., Kennedy I.M., Barakat A.I. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ. Health Perspect. 2007, 115:403-409.
28. Gopee N.V., Roberts D.W., Webb P., Cozart C.R., Siitonen P.H., Warbritton A.R., Yu W.W., Colvin V.L., Walker N.J., Howard P.C. Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol. Sci. 2007, 98:249-257.
29. Gulson B., McCall M., Korsch M., Gomez L., Casey P., Oytam Y., Taylor A., McCulloch M., Trotter J., Kinsley L., Greenoak G. Small amounts of zinc from zinc oxide particles in sunscreens applied outdoors are absorbed through human skin. Toxicol. Sci. 2010, 118:140-149.
30. Hanley C., Layne J., Punnoose A., Reddy K.M., Coombs I., Coombs A., Feris K., Wingett D. Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles. Nanotechnology 2008, 19:295103.
31. Hanley C., Thurber A., Hanna C., Punnoose A., Zhang J., Wingett D.G. The influences of cell type and ZnO nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Res. Lett. 2009, 4:1409-1420.
32. 2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Chemosphere 2008, 71:308-1316.
33. Heng B.C., Zhao X., Xiong S., Ng K.W., Boey F.Y., Loo J.S. Toxicity of zinc oxide (ZnO) nanoparticles on human bronchial epithelial cells (BEAS-2B) is accentuated by oxidative stress. Food Chem. Toxicol. 2010, 48:1762-1766.
34. 2 nanoparticles toward human lung epithelial cells. Sci. Total Environ. 2011, 409:1219-1228.
35. Huang C.C., Aronstam R.S., Chen D.R., Huang Y.W. Oxidative stress, calcium homeostasis, and altered gene expression in human lung epithelial cells exposed to ZnO nanoparticles. Toxicol. In Vitro 2010, 24:45-55.
36. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 2006, 116:1218-1222.
37. Jeng H.A., Swanson J. Toxicity of metal oxide nanoparticles in mammalian cells. J. Environ. Sci. Health 2006, 41:2699-2711.
38. Ji S.L., Ye C.H. Synthesis, growth mechanism, and applications of zinc oxide nanomaterials. J. Mater. Sci. Technol. 2008, 24:457-472.
39. Jo E., Seo G., Kwon J.T., Lee M., Lee B.c., Eom I., Kim P., Choi K. Exposure to zinc oxide nanoparticles affects reproductive development and biodistribution in offspring rats. J. Toxicol. Sci. 2013, 38:525-530.
40. Kang T., Guan R., Chen X., Song Y., Jiang H., Zhao J. In vitro toxicity of different-sized ZnO nanoparticles in Caco-2 cells. Nanoscale Res. Lett. 2013, 8:496.
41. Karlsson H.L., Cronholm P., Gustafsson J., Moller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21:1726-1732.
42. Kim Y.H., Fazlollahi F., Kennedy I.M., Yacobi N.R., Hamm-Alvarez S.F., Borok Z., Kim K.J., Crandall E.D. Alveolar epithelial cell injury due to zinc oxide nanoparticle exposure. Am. J. Respir. Crit. Care Med. 2010, 182:1398-1409.
43. Kuschner W.G., D'Alessandro A., Wintermeyer S.F., Wong H., Boushey H.A., Blanc P.D. Pulmonary responses to purified zinc oxide fume. J. Investig. Med. 1995, 43:371-378.
44. Lai J.C.K., Lai M.B., Jandhyam S., Dukhande V.V., Bhushan A., Daniels C.K., Leung S.W. Exposure to titanium dioxide and other metallic oxide nanoparticles induces cytotoxicity on human neural cells and fibroblasts. Int. J. Nanomed. 2008, 3:533-545.
45. Li C.H., Shen C.C., Cheng Y.W., Huang S.H., Wu C.C., Kao C.C., Liao J.W., Kang J.J. Organ biodistribution, clearance, and genotoxicity of orally administered zinc oxide nanoparticles in mice. Nanotoxicology 2012, 6:746-756.
46. Lin W., Xu Y., Huang C.C., Ma Y., Shannon K.B., Chen D.R., Huang Y.W. Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells. J. Nanopart. Res. 2009, 11:25-33.
47. Mercer R.R., Hubbs A.F., Scabilloni J.F., Wang L.Y., Battelli L.A., Schwegler-Berry D., Castranova V., Porter D.W. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part. Fibre Toxicol. 2010, 7:28.
48. Mercurio F., Manning A.M. NF-kappaB as a primary regulator of the stress response. Oncogene 1999, 18:6163-6171.
49. Meyer K., Rajanahalli P., Ahamed M., Rowe J.J., Hong Y. ZnO nanoparticles induce apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicol. In Vitro 2011, 25:1721-1726.
50. Moos P.J., Chung K., Woessner D., Honeggar M., Cutler N.S., Veranth J.M. ZnO particulate matter requires cell contact for toxicity in human colon cancer cells. Chem. Res. Toxicol. 2010, 23:733-739.
51. Muller J., Huaux F., Fonseca A., Nagy J.B., Moreau N., Delos M., Raymundo-Piñero E., Béguin F., Kirsch-Volders M., Fenoglio I., Fubini B., Lison D. Structural defects play a major role in the acute lung toxicity of multiwalled carbon nanotubes: toxicological aspects. Chem. Res. Toxicol. 2008, 21:1698-1705.
52. Nakae S., Saijo S., Horai R., Sudo K., Mori S., Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5986-5990.
53. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
54. Ng K.W., Khoo S.P., Heng B.C., Setyawati M.I., Tan E.C., Zhao X., Xiong S., Fang W., Leong D.T., Loo J.S. The role of the tumor suppressor p53 pathway in the cellular DNA damage response to zinc oxide nanoparticles. Biomaterials 2011, 32:8218-8225.
55. Niemeyer C.M. Nanoparticles, proteins, and nucleic acids: biotechnology meets materials science. Angew. Chem. Int. Ed. 2001, 40:4128-4158.
56. Oberdorster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ. Health Perspect. 2004, 112:1058-1062.
57. Oberdorster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling berdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
58. Osman I.F., Baumgartner A., Cemeli E., Fletcher J.N., Anderson D. Genotoxicity and cytotoxicity of zinc oxide and titanium dioxide in HEp-2 cells. Nanomedicine (Lond.) 2010, 5:1193-1203.
59. Osmond M.J., McCall M.J. Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard. Nanotoxicology 2010, 4:15-41.
60. Osmond-McLeod M.J., Oytam Y., Kirby J.K., Gomez-Fernandez L., Baxter B., McCall M.J. Dermal absorption and short-term biological impact in hairless mice from sunscreens containing zinc oxide nano- or larger particles. Nanotoxicology 2014, 8:72-84.
61. Palomäki J., Karisola P., Pylkkänen L., Savolainen K., Alenius H. Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells. Toxicology 2010, 267:125-131.
62. Prach M., Stone V., Proudfoot L. Zinc oxide nanoparticles and monocytes: impact of size, charge and solubility on activation status. Toxicol. Appl. Pharmacol. 2013, 266:19-26.
63. Pujalté I., Passagne I., Brouillaud B., Tréguer M., Durand E., Ohayon-Courtès C., L'Azou B. Cytotoxicity and oxidative stress induced by different metallic nanoparticles on human kidney cells. Part. Fibre Toxicol. 2011, 8:10.
64. Romagnano S. Regulation of the T cell response. Clin. Exp. Allergy 2006, 36:1357-1366.
65. Rothen-Rutishauser B., Mühlfeld C., Blank F., Musso C., Gehr P. Translocation of particles and inflammatory responses after exposure to fine particles and nanoparticles in an epithelial airway model. Part. Fibre Toxicol. 2007, 4:9.
66. Roy R., Kumar S., Verma A.K., Sharma A., Chaudhari B.P., Tripathi A., Das M., Dwivedi P.D. Zinc oxide nanoparticles provide an adjuvant effect to ovalbumin via a Th2 response in Balb/c mice. Int. Immunol. 2014, 26:159-172.
67. Roy R., Tripathi A., Das M., Dwivedi P.D. Cytotoxicity and uptake of zinc oxide nanoparticles leading to enhanced inflammatory cytokines levels in murine macrophages: comparison with bulk zinc oxide. J. Biomed. Nanotechnol. 2011, 7:110-111.
68. Sahu D., Kannan G.M., Vijayaraghavan R., Anand T., Khanum F. Nanosized zinc oxide induces toxicity in human lung cells. ISRN Toxicol. 2013, 2013:316075.
69. Sayes C.M., Reed K.L., Warheit D.B. Assessing Toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 2007, 97:163-180.
70. 2+ permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:2414-2419.
71. Sharma V., Anderson D., Dhawan A. Zinc oxide nanoparticles induce oxidative DNA damage and ROS-triggered mitochondria mediated apoptosis in human liver cells (HepG2). Apoptosis 2012, 17:852-870.
72. Sharma V., Shukla R.K., Saxena N., Parmar D., Das M., Dhawan A. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett. 2009, 185:211-218.
73. Shen C., James S.A., de Jonge M.D., Turney T.W., Wright P.F., Feltis B.N. Relating cytotoxicity, zinc ions, and reactive oxygen in ZnO nanoparticle-exposed human immune cells. Toxicol. Sci. 2013, 136:120-130.
74. Song W., Zhang J., Guo J., Zhang J., Ding F., Li L., Sun Z. Role of the dissolved zinc ion and reactive oxygen species in cytotoxicity of ZnO nanoparticles. Toxicol. Lett. 2010, 199:389-397.
75. Takenaka S., Karg E., Roth C., Schulz H., Ziesenis A., Heinzmann U., Schramel P., Heyder J. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ. Health Perspect. 2001, 109:547-551.
76. Tuomela S., Autio R., Buerki-Thurnherr T., Arslan O., Kunzmann A., Andersson-Willman B., Wick P., Mathur S., Scheynius A., Krug H.F., Fadeel B., Lahesmaa R. Gene expression profiling of immune-competent human cells exposed to engineered zinc oxide or titanium dioxide nanoparticles. PLOS ONE 2013, 8:e68415.
77. Wang D., Guo D., Bi H., Wu Q., Tian Q., Du Y. Zinc oxide nanoparticles inhibit Ca(2+)-ATPase expression in human lens epithelial cells under UVB irradiation. Toxicol. In Vitro 2013, 27:2117-2126.
78. Wang L., Nagesha D.K., Selvarasah S., Dokmeci M.R., Carrier R.L. Toxicity of CdSe nanoparticles in Caco-2 cell cultures. J. Nanobiotechnol. 2008, 6:11.
79. Wu W., Samet J.M., Peden D.B., Bromberg P.A. Phosphorylation of p65 is required for Zinc Oxide nanoparticle-induced interleukin 8 expression in human bronchial epithelial cells. Environ. Health Perspect. 2010, 118:982-987.
80. Xia T., Kovochich M., Liong M., Mädler L., Gilbert B., Shi H., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134.
81. Xia T., Zhao Y., Sager T., George S., Pokhrel S., Li N., Schoenfeld D., Meng H., Lin S., Wang X., Xie Y., Wang Y., Zhang T., Ren G., Yang Z. Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors. J. Biomed. Sci. 2012, 19:14.
82. Xia T., Zhao Y., Sager T., George S., Pokhrel S., Li N., Schoenfeld D., Meng H., Lin S., Wang X., Wang M., Ji Z., Zink J.I., Mädler L., Castranova V., Lin S., Nel A.E. Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano 2011, 5:1223-1235.
83. Xie Y., Wang Y., Zhang T., Ren G., Yang Z. Effects of nanoparticle zinc oxide on spatial cognition and synaptic plasticity in mice with depressive-like behaviors. J. Biomed. Sci. 2012, 19:14.
84. Xie Y., Williams N.G., Tolic A., Chrisler W.B., Teeguarden J.G., Maddux B.L.S., Pounds J.G., Laskin A., Orr G. Aerosolized ZnO nanoparticles induce toxicity in alveolar type II epithelial cells at the air-liquid interface. Toxicol. Sci. 2012, 125:450-461.
85. Yang H., Liu C., Yang D., Zhang H., Xia Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 2009, 29:69-78.
86. Yang S.T., Liu J.H., Wang J., Yuan Y., Cao A., Wang H., Liu Y., Zhao Y. Cytotoxicity of zinc oxide nanoparticles: importance of microenvironment. J. Nanosci. Nanotechnol. 2010, 10:8638-8645.
87. Yin H., Casey P.S., McCall M.J. Surface modifications of ZnO nanoparticles and their cytotoxicity. J. Nanosci. Nanotechnol. 2010, 10:7565-7570.
88. Yu K.N., Yoon T.J., Minai-Tehrani A., Kim J.E., Park S.J., Jeong M.S., Ha S.W., Lee J.K., Kim J.S., Cho M.H. Zinc oxide nanoparticle induced autophagic cell death and mitochondrial damage via reactive oxygen species generation. Toxicol. In Vitro 2013, 27:1187-1195.
89. Zhang X., Bai R., Tong Y.W. Selective adsorption behaviors of proteins on polypyrrole-based adsorbents. Sep. Purif. Technol. 2006, 52:161-169.
90. Zhou Y.M., Zhong C.Y., Kennedy I.M., Leppert V.J., Pinkerton K.E. Oxidative stress and NF kappa B activation in the lungs of rats: a synergistic interaction between soot and iron particles. Toxicol. Appl. Pharm. 2003, 190:157-169.